CHELSI STEARNS: Open Payments
NPI 1306495890 · COLUMBUS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$275 in 14 payments from 8 companies in 2025. Trend: 2023 $2,583 · 2024 $173 · 2025 $275
Food & beverage: $275
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $77 |
| Biogen, Inc. | 3 | $68 |
| Astellas Pharma US Inc | 2 | $49 |
| CooperSurgical, Inc. | 1 | $26 |
| MILLICENT US INC | 1 | $16 |
| Novo Nordisk Inc | 1 | $14 |
| Exeltis, USA Inc. | 1 | $13 |
| Organon LLC | 1 | $13 |
Products named: ZURZUVAE, LILETTA, Veozah, Paragard T 380A, VRAYLAR, FEMLYV, Wegovy, SLYND.
Industry payments across IN — which companies pay providers there.
